Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Head-and-Neck Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT06130007
What this trial is testing

A Prospective, Single-arm Phase II Clinical Trial of Tislelizumab Combined With Platinum Doublet Neoadjuvant Therapy to Improve Mandibular Preservation in Resectable Locally Advanced Oral Squamous Cell Carcinoma.

Who this might be right for
Oral Squamous Cell Carcinoma
Xuekui Liu 48
Testing effectiveness (Phase 2)UnknownNCT02123381
What this trial is testing

Changes in Tumor Tissue and Serum Biomarkers Before and After Cetuximab Combined With Preoperative Radiotherapy in Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma

Who this might be right for
Locally Advanced Thoracic Middle-lower Segment Esophageal Squamous Cell Carcinoma
Sichuan Cancer Hospital and Research Institute 100
Early research (Phase 1)Study completedNCT02586207
What this trial is testing

Pembrolizumab in Combination With CRT for LA-SCCHN

Who this might be right for
Head and Neck CancerSquamous Cell CarcinomaOral Cavity Cancer+4 more
Sanford Health 59
Not applicableEnrolling By InvitationNCT07567716
What this trial is testing

Infiltration Pattern of Locally Advanced ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)InfiltrationTumour
Shanghai Chest Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00757172
What this trial is testing

Panitumumab, Docetaxel, Cisplatin, Radiation Therapy, and Surgery in Treating Patients With Newly Diagnosed, Locally Advanced Esophageal Cancer or Cancer of the Gastroesophageal Junction

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionEsophageal Cancer
Alliance for Clinical Trials in Oncology 70
Early research (Phase 1)Ended earlyNCT00368329
What this trial is testing

Phase I Dose Escalation of Stereotactic Radiosurgical Boost for Locally Advanced Esophageal Cancer

Who this might be right for
Esophageal NeoplasmsCarcinoma, Squamous CellAdenocarcinoma+1 more
Stanford University 4
Testing effectiveness (Phase 2)Study completedNCT02360501
What this trial is testing

Combination of Docetaxel, Cisplatin, and Capecitabine (DCX) in the Treatment of Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Neoplasms
Sun Yat-sen University 50
Large-scale testing (Phase 3)UnknownNCT02465736
What this trial is testing

Study of Docetaxel or Vinorelbine Plus Cisplatin in Neoadjuvant Chemoradiotherapy for Esophageal Cancer (NEOCRTEC308)

Who this might be right for
Esophageal Squamous Cell CarcinomaEsophageal CancerOesophageal Cancer
Sun Yat-sen University 610
Testing effectiveness (Phase 2)UnknownNCT00855881
What this trial is testing

Metronomic Chemotherapy With Tegafur/Uracil for Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Cancer
Mackay Memorial Hospital 115
Testing effectiveness (Phase 2)Study completedNCT05294900
What this trial is testing

Trial of Neoadjuvant Therapy With Paclitaxel and Carboplatin in Operable Locally Advanced Head and Neck Cancer Patients

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Yonsei University 79
Large-scale testing (Phase 3)WithdrawnNCT01345084
What this trial is testing

Study Comparing Radiation Therapy and Chemotherapy With or Without Nimotuzumab

Who this might be right for
CarcinomaHead and Neck Cancer
Eurofarma Laboratorios S.A.
Testing effectiveness (Phase 2)Ended earlyNCT01192815
What this trial is testing

Erlotinib Hydrochloride and Radiation Therapy in Stage III-IV Squamous Cell Cancer of the Head and Neck

Who this might be right for
Stage III Squamous Cell Carcinoma of the HypopharynxStage III Squamous Cell Carcinoma of the LarynxStage III Squamous Cell Carcinoma of the Lip and Oral Cavity+9 more
Case Comprehensive Cancer Center 2
Large-scale testing (Phase 3)Looking for participantsNCT05125055
What this trial is testing

Neoadjuvant Anti-PD-1 and TP Versus TPF on Pathological Response in OSCC

Who this might be right for
Oral Squamous Cell CarcinomaNeoadjvant TherapyAnti-PD-1+1 more
Shanghai Jiao Tong University School of Medicine 80
Not applicableStudy completedNCT01484847
What this trial is testing

PF-00299804 When Given Through a Feeding Tube in Locally Advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
University Health Network, Toronto 6
Testing effectiveness (Phase 2)Active Not RecruitingNCT05668858
What this trial is testing

SI-B001+SI-B003± Chemotherapy in Patients With Locally Advanced or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
Sichuan Baili Pharmaceutical Co., Ltd. 70
Testing effectiveness (Phase 2)Study completedNCT02114658
What this trial is testing

Sorafenib Phase II Study for Japanese Anaplastic or Medullary Thyroid Carcinoma Patients

Who this might be right for
Thyroid Carcinoma
Bayer 18
Large-scale testing (Phase 3)UnknownNCT04426955
What this trial is testing

Study of Camrelizumab (SHR-1210) in Combination With Concurrent Chemoradiotherapy in Locally Advanced Esophageal Cancer

Who this might be right for
Esophageal Cancer
Jiangsu HengRui Medicine Co., Ltd. 396
Testing effectiveness (Phase 2)UnknownNCT03051906
What this trial is testing

Durvalumab, Cetuximab and Radiotherapy in Head Neck Cancer

Who this might be right for
Head and Neck Neoplasms
Azienda Ospedaliero-Universitaria Careggi 69
Testing effectiveness (Phase 2)Looking for participantsNCT07381075
What this trial is testing

A Phase II Clinical Trial of Anti-EGFR Antibody-drug Conjugate (ADC) Combined With or Without Immune Checkpoint Inhibitors in the Neoadjuvant Treatment of Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
West China Hospital 90
Not applicableLooking for participantsNCT06182657
What this trial is testing

The Prognostic Value of the Degree of Pathological Response of Induction Chemotherapy for NPC

Who this might be right for
Nasopharyngeal CarcinomaPathologic Complete ResponseTumor Microenvironment
Jiangxi Provincial Cancer Hospital 300
Next Page